1.0880
-0.0215
(-1.94%)
As of 8:03:45 AM GMT+2. Market Open.
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 280.46k | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
LUCERA ERICK J. Chief Financial Officer | Sale at price 1.71 per share. | Direct | 7,030 | Mar 4, 2025 |
O NEILL GILMORE NEIL Chief Executive Officer | Sale at price 1.71 per share. | Direct | 28,452 | Mar 4, 2025 |
BURKLY LINDA Officer | Sale at price 1.71 per share. | Direct | 4,946 | Mar 4, 2025 |
O NEILL GILMORE NEIL Chief Executive Officer | Sale at price 2.08 per share. | Direct | 3,361 | Dec 3, 2024 |
MEI BAISONG Officer | Sale at price 2.08 per share. | Direct | 1,124 | Dec 3, 2024 |
O NEILL GILMORE NEIL Chief Executive Officer | Sale at price 3.42 per share. | Direct | 5,325 | Sep 4, 2024 |
MEI BAISONG Officer | Sale at price 3.42 per share. | Direct | 1,774 | Sep 4, 2024 |
BURKLY LINDA Officer | Sale at price 5.42 per share. | Direct | 64,370 | Jul 25, 2024 |
MEI BAISONG Officer | Sale at price 5.21 per share. | Direct | 34,456 | Jul 19, 2024 |
O NEILL GILMORE NEIL Chief Executive Officer | Sale at price 5.50 per share. | Direct | 66,997 | Jun 4, 2024 |
MEI BAISONG Officer | Sale at price 5.50 per share. | Direct | 2,808 | Jun 4, 2024 |
LUCERA ERICK J. Chief Financial Officer | Sale at price 5.61 per share. | Direct | 125,404 | May 20, 2024 |
HOPFIELD JESSICA Director | Purchase at price 5.64 per share. | Direct | 253,868 | May 13, 2024 |
O NEILL GILMORE NEIL Chief Executive Officer | Sale at price 9.42 per share. | Direct | 732,884 | Mar 5, 2024 |
MEI BAISONG Officer | Sale at price 9.42 per share. | Direct | 191,425 | Mar 4, 2024 |
LUCERA ERICK J. Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
O NEILL GILMORE NEIL Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
MEI BAISONG Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
BURKLY LINDA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
EATON BRUCE E Chairman of the Board | Sale at price 10.90 per share. | Direct | 1,122 | Dec 5, 2023 |
EATON BRUCE E Chief Technology Officer | Sale at price 8.21 per share. | Direct | 5,706 | Nov 14, 2023 |
EATON BRUCE E Chief Technology Officer | Sale at price 8.40 per share. | Direct | 1,168 | Nov 7, 2023 |
EATON BRUCE E Chief Technology Officer | Sale at price 8.82 per share. | Direct | 908 | Sep 6, 2023 |
EATON BRUCE E Chairman of the Board | Sale at price 8.59 per share. | Direct | 6,033 | Aug 11, 2023 |
EATON BRUCE E Chairman of the Board | Sale at price 8.39 per share. | Direct | 1,183 | Aug 8, 2023 |
BURKLY LINDA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 24, 2023 |
MEI BAISONG Officer | Sale at price 8.80 per share. | Direct | 37,990 | Jul 19, 2023 |
EATON BRUCE E Chairman of the Board | Sale at price 9.50 per share. | Direct | 998 | Jun 5, 2023 |
O NEILL GILMORE NEIL Chief Executive Officer | Sale at price 9.50 per share. | Direct | 61,638 | Jun 5, 2023 |
LUCERA ERICK J. Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 17, 2023 |
EATON BRUCE E Chief Technology Officer | Sale at price 9.87 per share. | Direct | 6,594 | May 11, 2023 |
ROBERTSON MICHELLE Chief Financial Officer | Sale at price 9.87 per share. | Direct | 9,369 | May 11, 2023 |
EATON BRUCE E Chief Technology Officer | Sale at price 9.51 per share. | Direct | 1,284 | May 9, 2023 |
Related Tickers
1FW2.F WuXi Biologics (Cayman) Inc.
2.2410
-7.95%
0K4.F Akero Therapeutics, Inc.
32.93
+0.09%
IVA.PA Inventiva S.A.
2.8450
+0.18%
22UA.DE BioNTech SE
87.80
-0.28%
NVCT Nuvectis Pharma, Inc.
9.53
-2.56%
IMAB I-Mab
0.9072
-5.07%
FGEN FibroGen, Inc.
0.2962
-1.23%
ATRA Atara Biotherapeutics, Inc.
5.98
+2.22%
ETNB 89bio, Inc.
6.05
+2.20%
OCUL Ocular Therapeutix, Inc.
7.53
-0.53%